BioConvergence pour la
Santé
Domaine d’Intérêt Majeur (DIM) de la Région Île-de-France
What is Bioconvergence?
Bioconvergence is the integration of biology with other fields like engineering, physics, and data science to create innovative solutions in healthcare, biotechnology, and beyond. It involves combining the principles and tools of these disciplines to address complex biological challenges more effectively. By merging biological systems with technological advancements, bioconvergence enables breakthroughs in areas such as precision medicine, advanced therapeutics, and biofabrication. This interdisciplinary approach accelerates the development of novel diagnostics, treatments, and sustainable biomanufacturing processes, fostering a new era of innovation that leverages the strengths of diverse scientific domains.
BioConvS at VivaTech 2025
We’re pleased to share that the DIM BioConvS will be participating in VivaTechnology 2025 as part of the Région Île-de-France delegation. VivaTech is Europe’s largest startup and tech event, bringing together over 150,000 participants, including investors,...
Innovation Day 2025
The DIM BioConvS 2025 Symposium will take place on November 26 at the Conseil Régional d'Île-de-France. This year’s Innovation Day, titled Joining Forces, will celebrate the power of collaboration at the crossroads of synthetic biology, biotherapies, and technological...
PhDon’t quit!
Phd students in Île-de-France, this is for you! Join us for an afterwork where every conversation counts! 😵💫 Struggling with an experiment? 🧐 Looking for a collaborator? 😩 About to quit your phD because your antibody doesn't work? Don’t quit! Someone already wanted...
2025 equipment call
The DIM BioConvS' 2025 equipment call is open until June 1st, 2025. This call aims to fund up to 750k€ for research equipment for academic labs within Ile-de-France that are members of BioConvS and work in the thematics of biotherapy and bioproduction. The...
2025 PhD fellowship call
The DIM BioConvS' PhD Fellowships Call will open in mid-january 2025. This call aims to fund four PhD grants for students working in academic labs within Ile-de-France that are members of BioConvS. Academic labs interested in applying for these grants but are not yet...
BioConvS x Pint of Science 2025
For the second consecutive year, the DIM BioConvS renews its partnership with Université Paris Cité to support the Pint of Science festival. In 2025, this collaboration focuses on sponsoring the entire series of evenings hosted at the bar La Pomme d’Ève in Paris. Pint...
Inventors challenge
Register to the “Défi Inventeur et Inventrice 2025” What do we offer? Promote your research work and explore new opportunities to have a real impact on society and science. The program offers partipants a hands-on workshop to stimulate their inventiveness, along with...
Call for Expression of Interest – POD
What is this call for expressions of Interest? The Proof-of-concept demonstrator (POD) call for expressions of interest aims to identify projects in the field of biotherapies, requiring to de-risk innovation with the support of an industrial integrator at Paris...
![[closed] Our 2024 postdoc call is open](https://bioconvs.org/wp-content/uploads/2023/10/DSC_0333-scaled-1-400x250.jpg)
[closed] Our 2024 postdoc call is open
Our 2024 postdoc call, which will fund 2 postdoctoral 2-year fellowships in the field of synthetic biology for health, is open until March 2nd, 2025. This call will fund fellowships for a project in collaboration between two academic research laboratories; an...
What is BioConvS?
BioConvergence for Health (BioConvS) is a Domain of Major Research and Innovation (DIM) funded by the Ile de France region. It aims to structure the communities of synthetic biology, biotherapy and bioproduction to guide the transition from scientific excellence to innovation, and to position Île-de-France region as an international reference in the domain. BioConvS, led by Université Paris Cité in partnership with Sorbonne and Paris-Saclay universities, Curie Institute (PSL), Micalis Institute (INRAe), Evry Genopole cluster, APHP and INSERM groups actors from the public and private sectors and benefits from 12.5M€ support from the Ile de France Region.
Principal axes
BioConvS gathers the Île-de-France scientific community working on the following axes:
- Life sciences engineering and bioproduction
- Development of therapeutics proofs-of-principles
- New, high throughput, standardisable analythic methods
- Digital or AI tools to improve data analysis or modelling in quality control and production methods
- Guarantee an inclusive, ethical, sustainable Bioconvergence
Distributed Biofoundry
BioConvS will support a network of distributed biofounderies (with the participation of Sorbonne University, INRAe, Institut Curie, Genopole and Université Paris Cité) to make technologies for life design and engineering accessible to Île-de-France Region public and private R&D. This will include the acquisition and pooling of high-tech equipment dedicated to the molecular engineering of living systems and bioproduction to create genetic circuits, synthetic cells and bioprocesses on demand.
CollectivE Digital Intelligence Platform (DICE)
BioConvS will develop an AI-supported framework of digital resources to design, document and share BioConvS researchers’ profiles, expertise and projects in a virtual collaborative research space. This platform, open to the general public, will strengthen the capacity for exchange between DIM’s partners and society.
Consult our data protection policy
Address:
DIM BioConvS
Faculté des Sciences - Université Paris Cité
5 rue Thomas Mann 75013 Paris
